Categories
Picks

Eli Lilly & Co. (NYSE: LLY)

Eli Lilly is one of the world’s largest pharmaceutical companies. It is a leading producer of a new type of diabetes/weight loss drug. Eli Lilly’s trade name for their drug is Mounjaro. It was approved in the US in 2022 for treatment of Type 2 diabetes and is expected to be approved as a weight-loss drug by year-end.

Wealth Builder

Sorry!

Only current subscribers of the Internet Wealth Builder may view the details of this recommendation.






Interactive Performance Chart

LLY was first recommended here on October 15, 2023